or
forgot password

    • cancer clinical trials in peru, IL

    • Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Illinois Valley Hospital
    Peru, Illinois 61354
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Leukemia
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Illinois CancerCare - Peru
    Peru, Illinois 61354
    Brain and Central Nervous System Tumors
    Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Illinois Valley Hospital
    Peru, Illinois 61354
    Recurrent Mantle Cell Lymphoma
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    Neuroendocrine Carcinoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Illinois Valley Hospital

    Trial Locations
    Illinois Valley Hospital
    Illinois CancerCare-Peru
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Lymphoma
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Lymphoma
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Breast Cancer
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Liver Cancer
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Brain and Central Nervous System Tumors
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Illinois CancerCare - Peru
    Peru, Illinois 61354
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Ovarian Cancer, Sarcoma
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Illinois Valley Community Hospital

    Trial Locations
    Illinois Valley Community Hospital
    Illinois CancerCare - Peru
    Brain and Central Nervous System Tumors, Neurotoxicity
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Illinois CancerCare - Peru
    Peru, Illinois 61354
    Breast Cancer, Cardiac Toxicity